It’s been over a year since my office shut down. Over a year since I went to a bar, a fitness class, a movie theater, a concert, a Knicks game, or to the many other public events that were once centerpieces of my social life.
But there’s finally, finally a finish line in sight. There are three safe and effective COVID-19 vaccines authorized and available in the US — and at least 90 percent of all adults will be eligible to receive one by April 19th. If our current vaccination pace continues, 75 percent of adults will have at least one dose by early summer. Reader, I am dying to get back to my favorite activities, and I can tell that people around me are, too.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).
